Literature DB >> 11799195

Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.

Karen L Mossman1, James R Smiley.   

Abstract

Interferon inhibits virus replication through multiple mechanisms. Here we show that herpes simplex virus proteins ICP0 and ICP34.5 overcome interferon-induced barriers to viral transcription and translation, respectively. These cytokine-induced antiviral mechanisms are differentially expressed in established cell lines: U2OS cells do not mount the IFN-induced mechanism targeted by ICP0, and Vero cells may be defective for the mechanism targeted by ICP34.5.

Mesh:

Substances:

Year:  2002        PMID: 11799195      PMCID: PMC135894          DOI: 10.1128/jvi.76.4.1995-1998.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1.

Authors:  J Chou; J J Chen; M Gross; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

2.  Characterization of the early steps of herpes simplex virus replication in interferon-treated human cells.

Authors:  F Oberman; A Panet
Journal:  J Interferon Res       Date:  1989-10

3.  Specific effect of interferon on the herpes simplex virus type 1 transactivation event.

Authors:  P R De Stasio; M W Taylor
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  Differential response of human cells to deletions and stop codons in the gamma(1)34.5 gene of herpes simplex virus.

Authors:  J Chou; A P Poon; J Johnson; B Roizman
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage.

Authors:  J Chou; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

6.  Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0).

Authors:  G G Maul; H H Guldner; J G Spivack
Journal:  J Gen Virol       Date:  1993-12       Impact factor: 3.891

7.  ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures.

Authors:  C A Bolovan; N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1.

Authors:  F Yao; P A Schaffer
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription.

Authors:  S Mittnacht; P Straub; H Kirchner; H Jacobsen
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

10.  The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells.

Authors:  J Chou; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

View more
  66 in total

1.  The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.

Authors:  Rongtuan Lin; Ryan S Noyce; Susan E Collins; Roger D Everett; Karen L Mossman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and gamma(1)34.5 gene products.

Authors:  Matthew Mulvey; Vladimir Camarena; Ian Mohr
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5.

Authors:  Junji Xing; Shuai Wang; Rongtuan Lin; Karen L Mossman; Chunfu Zheng
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture.

Authors:  Cristina Barreca; Peter O'Hare
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

6.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

7.  Handling of the cotton rat in studies for the pre-clinical evaluation of oncolytic viruses.

Authors:  Breanne Cuddington; Meghan Verschoor; Karen Mossman
Journal:  J Vis Exp       Date:  2014-11-24       Impact factor: 1.355

8.  Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production.

Authors:  Shuai Wang; Kezhen Wang; Rongtuan Lin; Chunfu Zheng
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

9.  Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA.

Authors:  Jiaxi Wu; Lijun Sun; Xiang Chen; Fenghe Du; Heping Shi; Chuo Chen; Zhijian J Chen
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

10.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.